Adenosine A₂A and A₂B receptors are both required for adenosine A₁ receptor-mediated cardioprotection.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  American Journal of Physiology. Heart and Circulatory Physiology

• Publication date

  2011-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1152/ajpheart.00264.2011PMID 21743001PMCID PMC3191080
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adenosine Receptor-Mediated Cardioprotection

  2012cited by this paper
• Cooperative Cardioprotection Through Adenosine A1 and A2A Receptor Agonism in Ischemia-Reperfused Isolated Mouse Heart

  2010influential reference
• Evidence that the acute phase of ischemic preconditioning does not require signaling by the A 2B adenosine receptor.

  2010cited by this paper
• A(3) adenosine receptor activation during reperfusion reduces infarct size through actions on bone marrow-derived cells.

  2010cited by this paper
• Differential effects of adenosine A2a and A2b receptors on cardiac contractility.

  2010influential reference
• Both A2a and A2b adenosine receptors at reperfusion are necessary to reduce infarct size in mouse hearts.

  2010influential reference
• Adenosine A2A and A2B receptors work in concert to induce a strong protection against reperfusion injury in rat hearts.

  2009influential reference
• Cardioprotection Induced by Adenosine A1 Receptor Agonists in a Cardiac Cell Ischemia Model Involves Cooperative Activation of Adenosine A2A and A2B Receptors by Endogenous Adenosine

  2009cited by this paper
• Adenosine receptors and reperfusion injury of the heart.

  2009cited by this paper
• Characterization of the A2B Adenosine Receptor from Mouse, Rabbit, and Dog

  2009cited by this paper
• Up-regulation of A 2B adenosine receptor in A 2A adenosine receptor knockout mouse coronary artery.

  2008cited by this paper
• The A3 Adenosine Receptor Agonist CP-532,903 [N6-(2,5-Dichlorobenzyl)-3′-aminoadenosine-5′-N-methylcarboxamide] Protects against Myocardial Ischemia/Reperfusion Injury via the Sarcolemmal ATP-Sensitive Potassium Channel

  2008cited by this paper
• Adenosine A2A receptor activation reduces infarct size in the isolated, perfused mouse heart by inhibiting resident cardiac mast cell degranulation.

  2008cited by this paper
• Infarct limitation by a protein kinase G activator at reperfusion in rabbit hearts is dependent on sensitizing the heart to A2b agonists by protein kinase C.

  2008influential reference
• Cardioprotection by Ecto-5′-Nucleotidase (CD73) and A2B Adenosine Receptors

  2007cited by this paper
• The A2a/A2b receptor antagonist ZM-241385 blocks the cardioprotective effect of adenosine agonist pretreatment in in vivo rat myocardium.

  2007influential reference
• Adenosinergic cardioprotection: multiple receptors, multiple pathways.

  2007cited by this paper
• Enhanced mast cell activation in mice deficient in the A2b adenosine receptor

  2007cited by this paper
• Myocardial Infarct–Sparing Effect of Adenosine A2A Receptor Activation Is due to Its Action on CD4+ T Lymphocytes

  2006cited by this paper
• In vivo adenosine receptor preconditioning reduces myocardial infarct size via subcellular ERK signaling.

  2005influential reference
• Activation of protein kinase B by adenosine A1 and A3 receptors in newborn rat cardiomyocytes.

  2004cited by this paper
• Enabling role of adenosine A1 receptors in adenosine A2A receptor‐mediated striatal expression of c‐fos

  2003cited by this paper
• Adenosine A(2A) receptor facilitation of hippocampal synaptic transmission is dependent on tonic A(1) receptor inhibition.

  2002cited by this paper
• Cardiac myocyte adenosine A2a receptor activation fails to alter cAMP or contractility: role of receptor localization.

  2002cited by this paper
• [3H]MRS 1754, a selective antagonist radioligand for A(2B) adenosine receptors.

  2001cited by this paper
• Beneficial effects of adenosine A(2a) agonist CGS-21680 in infarcted and stunned porcine myocardium.

  2001cited by this paper
• Adenosine A1 Agonist at Reperfusion Trial (AART): Results of a Three-Center, Blinded, Randomized, Controlled Experimental Infarct Study

  2000cited by this paper
• Human adenosine A(1), A(2A), A(2B), and A(3) receptors expressed in Chinese hamster ovary cells all mediate the phosphorylation of extracellular-regulated kinase 1/2.

  2000cited by this paper
• Cross Talk Between A1 and A2A Adenosine Receptors in the Hippocampus and Cortex of Young Adult and Old Rats

  1999cited by this paper
• Adenosine A1receptor-mediated antiadrenergic effects are modulated by A2a receptor activation in rat heart.

  1999cited by this paper
• A2A Adenosine Receptor Deficiency Attenuates Brain Injury Induced by Transient Focal Ischemia in Mice

  1999cited by this paper
• Cross talk between A(1) and A(2A) adenosine receptors in the hippocampus and cortex of young adult and old rats.

  1999cited by this paper
• The time course of cardioprotection induced by GR79236, a selective adenosine A1-receptor agonist, in myocardial ischaemia-reperfusion injury in the pig.

  1999cited by this paper
• Adenosine A2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence.

  1997cited by this paper
• Selective adenosine A3 receptor stimulation reduces ischemic myocardial injury in the rabbit heart.

  1997cited by this paper
• Comparative pharmacology of human adenosine receptor subtypes – characterization of stably transfected receptors in CHO cells

  1997cited by this paper
• Selective activation of A3 adenosine receptors with N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits.

  1997cited by this paper
• Binding of the radioligand [3H]‐SCH 58261, a new non‐xanthine A2A adenosine receptor antagonist, to rat striatal membranes

  1996cited by this paper
• Inhibition of glycolysis and enhanced mechanical function of working rat hearts as a result of adenosine A1 receptor stimulation during reperfusion following ischaemia

  1996cited by this paper
• Intravenous Pretreatment With A1‐Selective Adenosine Analogues Protects the Heart Against Infarction

  1992cited by this paper
• The effects of intravenous infusions of selective adenosine A1-receptor and A2-receptor agonists on myocardial reperfusion injury.

  1992influential reference
• Adenosine improves recovery of postischemic myocardial function via an adenosine A1 receptor mechanism.

  1992cited by this paper
• [3H] 8 ‐Cyclopentyl‐1,3 ‐dipropylxanthine Binding to A1 Adenosine Receptors of Intact Rat Ventricular Myocytes

  1988cited by this paper
• 8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) — a selective high affinity antagonist radioligand for A1 adenosine receptors

  1987cited by this paper
• N6-cycloalkyladenosines. Potent, A1-selective adenosine agonists.

  1985cited by this paper

• Evaluation of Potential Molecular Targets of the Alkaloid Epiisopiloturine, Involved in Cardioprotective Effects, Using Computational Molecular Docking in an Animal Model of Cardiac Ischemia and Reperfusion

  2025cites this paper
• Network pharmacology integrated with experimental validation to elucidate the mechanisms of action of the Guizhi-Gancao Decoction in the treatment of phenylephrine-induced cardiac hypertrophy

  2024cites this paper
• Pharmacological Modulation of the Ca2+/cAMP/Adenosine Signaling in Cardiac Cells as a New Cardioprotective Strategy to Reduce Severe Arrhythmias in Myocardial Infarction

  2023cites this paper
• Protective Effects of Remote Ischemic Preconditioning on the Hearts of Liver Transplantation Patients

  2023cites this paper
• Problems and prospects for finding new pharmacological agents among adenosine receptor agonists, antagonists, or their allosteric modulators for the treatment of cardiovascular diseases.

  2023cites this paper
• Remote Conditioning by Rhythmic Compression of Limbs Ameliorated Myocardial Infarction by Downregulation of Inflammation via A2 Adenosine Receptors

  2022cites this paper
• Adenosine and Adenosine Receptors: Advances in Atrial Fibrillation

  2022cites this paper
• Role of Cardiac A2A Receptors Under Normal and Pathophysiological Conditions

  2021influential citation
• Pre- and post-conditioning of the heart: an overview of cardioprotective signaling pathways.

  2020cites this paper
• Recent Advances in the Role of the Adenosinergic System in Coronary Artery Disease.

  2020cites this paper
• Electroacupuncture improves myocardial ischemia injury via activation of adenosine receptors

  2020cites this paper
• Focusing on Adenosine Receptors as a Potential Targeted Therapy in Human Diseases

  2020cites this paper
• Recent Advances in Pharmacological and Non-Pharmacological Strategies of Cardioprotection

  2019cites this paper
• The adenosine A2B G protein-coupled receptor: Recent advances and therapeutic implications.

  2019cites this paper
• Cardioprotection of PLGA/gelatine cardiac patches functionalised with adenosine in a large animal model of ischaemia and reperfusion injury: A feasibility study

  2019cites this paper
• University of Birmingham Phenotyping of mice with heart specific overexpression of A2A-adenosine receptors

  2018cites this paper
• Phenotyping of Mice with Heart Specific Overexpression of A2A-Adenosine Receptors: Evidence for Cardioprotective Effects of A2A-Adenosine Receptors

  2018cites this paper
• Adenosine Receptor-Mediated Cardioprotection—Current Limitations and Future Directions

  2018cites this paper
• Regulation of protein kinase C-epsilon and its age-dependence.

  2017cites this paper
• Adenosine A1 receptor activation increases myocardial protein S-nitrosothiols and elicits protection from ischemia-reperfusion injury in male and female hearts

  2017cites this paper
• Caffeine Potentiates the Ergogenic Effects of Creatine

  2017cites this paper
• Adenosine receptors: regulatory players in the preservation of mitochondrial function induced by ischemic preconditioning of rat liver

  2016cites this paper
• Adenosine A2A and A2B Receptor Substantially Attenuate Ischemia/Reperfusion Injury in Septic rat Hearts

  2016cites this paper
• Transcriptional analysis caveolae-related transcripts in the ischaemic- intolerant ageing mouse heart

  2016cites this paper
• Ischaemic conditioning strategies reduce ischaemia/reperfusion-induced organ injury.

  2015cites this paper
• A2 Adenosine Receptor-mediated Cardioprotection Against Reperfusion Injury in Rat Hearts Is Associated With Autophagy Downregulation

  2015cites this paper
• Endogenous Cardioprotective Agents: Role in Pre and Postconditioning.

  2015cites this paper
• History and Perspectives of A2A Adenosine Receptor Antagonists as Potential Therapeutic Agents

  2015cites this paper
• ION CHANNELS, PROTEIN KINASE C AND CAVEOLAE IN CARDIOPROTECTION

  2015cites this paper
• Adenosine A2B receptor effects on post-MI remodeling and cardiac fibroblast function

  2014cites this paper
• Cardiac purinergic signalling in health and disease

  2014cites this paper
• Pharmacological postconditioning of the rabbit heart with non‐selective, A1, A2A and A3 adenosine receptor agonists

  2014cites this paper
• Structure-function studies with G protein-coupled receptors as a paradigm for improving drug discovery and therapeutic development

  2013cites this paper
• Adenosine inhibits renin release from juxtaglomerular cells via an A1 receptor-TRPC-mediated pathway.

  2013cites this paper
• Cardiovascular adenosine receptors: expression, actions and interactions.

  2013cites this paper
• Role of adenosine A(2B) receptor stimulation in ischaemic postconditioning: dawn of a new paradigm in cardioprotection.

  2012cites this paper
• A2 Adenosine Receptors and Vascular Pathologies

  2012cites this paper
• On-pump inhibition of es-ENT1 nucleoside transporter and adenosine deaminase during aortic crossclamping entraps intracellular adenosine and protects against reperfusion injury: role of adenosine A1 receptor.

  2012cites this paper
• Targeting adenosine receptors in the development of cardiovascular therapeutics

  2012cites this paper
• Regulation of Mitochondrial Function in Ischemia/Reperfusion: Looking for Therapeutic Strategies in Fatty Livers

  2012cites this paper
• Molecular mechanism underlying adenosine receptor-mediated mitochondrial targeting of protein kinase C.

  2012cites this paper
• Antigen generation and display in therapeutic antibody drug discovery – a neglected but critical player

  2012cites this paper
• Sex differences in the cardiac beta-adrenergic receptor contractile response

  2012cites this paper
• Structure‐function studies with G protein‐coupled receptors as a paradigm for improving drug discovery and development of therapeutics

  2012cites this paper